Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023 [PMID: PMC5143748 DOI: 10.3748/wjg.v22.i45.10015]
Corresponding Author of This Article
Mitsuhiro Kida, MD, PhD, Department of Gastroenterology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0375, Japan. m-kida@kitasato-u.ac.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023 Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 1 Demographic characteristics of all 53 patients
Characteristic
Value
Sex, No.
male/female: 26/27
Age, median (range), yr
63.0 (31-83)
Tumor location, No.
Esophagus/stomach/duodenum: 4/47/2
Table 2 Histopathological diagnosis
Esophagus (n = 4)
Stomach (n = 47)
Duodenum (n = 2)
Total(n = 53)
GIMT
4
45
0
49
GIST
0
34
0
34
Leiomyoma
2
3
0
5
Schwannoma
1
2
0
3
Spindle-cell tumor
1
6
0
7
Ectopic pancreas
0
1
0
1
Hamartoma
0
0
1
1
Intramural developmental cyst
0
1
0
1
Brunner’s adenoma
0
0
1
1
Table 3 Details of 53 patients
Resected tumors(n = 34)
Unresected tumors (n = 19)
Total (n = 53)
GIST (n = 34)
Follow-up period, median (range), mo
24.9 (6.6-210)
36.5 (11.2-183.6)
31.7 (6.6-210)
27.3 (6.6-210)
EUS sessions, median (range)
3 (2-8)
4 (2-13)
3 (2-13)
3 (2-11)
Tumor diameter at initial EUS, median (range), mm
19.5 (10-30)
19.0 (11.5-44.8)
19.1 (10-44.8)
19.0 (10.9-44.8)
Tumor diameter before surgery or FNA, median (range), mm
28.0 (20-43.1)
22.8 (15.2-52.1)
25.3 (13.7-52.1)
26.7 (13.7-52.1)
Time from the final EUS to surgery, median (range)
3.8 mo (22d-16.3 mo)
-
-
-
Table 4 Details of 34 patients with gastrointestinal submucosal tumors
Extremely low plus low risk (n = 28)
Intermediate risk(n = 3)
High risk (n = 3)
Total (n = 34)
Follow-up period, median (range), mo
31.0 (6.6-210)
47.3 (11.2-49.9)
12.4 (7.4-16.7)
27.3 (6.6-210)
Initial tumor diameter, median (range), mm
18.6 (10.9-30.0)
28.5 (20.0-44.8)
25.5 (14.0-27.3)
19.0 (10.9-44.8)
Doubling time, median (range), mo
24.0 (2.0-183.6)
17.1 (6.1-19.4)
3.9 (0.8-10.4)
17.2 (0.8-183.6)
Table 5 Tumors other than gastrointestinal submucosal tumors
No. of patient
Follow-up period, median (range), mo
Doubling time, median (range), mo
Leiomyoma
5
47.1 (10.7-137.2)
231.2 (21.3-1303.8)
Schwannoma
3
50.1 (24.3-71.7)
104.7 (3.9-305.4)
Ectopic pancreas
1
66.5
274.9
Hamartoma
1
99.6
61.2
Intramural developmental cyst
1
29.5
49.0
Brunner’s adenoma
1
30.6
134.7
Table 6 Comparison according to diagnosis
Doubling time (mo), median
P value
GIST vs Leiomyoma + schwannoma
17.2 vs 204.2
0.005
High risk vs Intermediate risk
3.9 vs 17.1
0.127
Intermediate risk vs Extremely low + low risk
17.1 vs 24.0
0.423
High risk vs Extremely low + low risk
3.9 vs 24.0
0.033
High + intermediate risk vs Extremely low + low risk
8.2 vs 24.0
0.047
Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023